SCHEMBL18565612

SCHEMBL18565612

c1ccc2c(c1)oc1cc(-c3ccc4c(c3)c3ccccc3n4-c3ccc(-c4nc(-n5c6ccccc6c6cc(-c7ccc8c(c7)oc7ccccc78)ccc65)nc(-n5c6ccccc6c6cc(-c7ccc8c(c7)oc7ccccc78)ccc65)n4)cc3)ccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.36
ATM Q13315 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
HCRTR1 O43613 1/20 0.36
AHR P35869 2/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
MAPT P10636 2/20 0.34
PTGER4 P35408 2/20 0.33
CHEK2 O96017 1/20 0.33
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.31
HSD17B10 Q99714 2/20 0.31
CASP3 P42574 1/20 0.31
SENP7 Q9BQF6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18565561 0.94 KDM4E (0.36) KDM4EATML3MBTL1HCRTR1AHR
SCHEMBL18565665 0.94 CHEK2 (0.38) KDM4EATML3MBTL1AHRMEN1
SCHEMBL18565591 0.94 KDM4E (0.38) KDM4EATML3MBTL1HCRTR1AHR
SCHEMBL18566007 0.93 CHEK2 (0.38) KDM4EATML3MBTL1AHRMEN1
SCHEMBL18565588 0.93 KDM4E (0.37) KDM4EATML3MBTL1HCRTR1AHR
SCHEMBL19626191 0.92 KDM4E (0.40) KDM4EATML3MBTL1HCRTR1AHR
SCHEMBL18565617 0.92 AHR (0.41) KDM4EATMHCRTR1AHRMEN1
SCHEMBL24303288 0.91 KDM4E (0.38) KDM4EATML3MBTL1HCRTR1AHR
SCHEMBL24149750 0.91 ATM (0.38) KDM4EATML3MBTL1HCRTR1AHR
SCHEMBL23317987 0.91 ATM (0.40) KDM4EATML3MBTL1HCRTR1AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-05-14 US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device EED, BMI1, CD99 KDM4E 225/4885ATM 3092/4885L3MBTL1 1263/4885
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 KDM4E 225/4885ATM 3092/4885L3MBTL1 1263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.